[1]
“Comparison of Stem Cell Mobilization Efficacy with Intermediate Dose Cytarabine Versus Cyclophosphamide or Plerixafor in Poor Mobilizers”, Вопр. онкол., vol. 70, no. 4, pp. 727–732, Sep. 2024, doi: 10.37469/0507-3758-2024-70-4-727-732.